| 1013-The Microbiota-Based Drug Rbx2660 is Efficacious and Safe in Patients with Recurrent Clostridium Difficile Infections: Results from 2 Controlled Clinical Trials PK Plumb, ER Dubberke, R Orenstein, S Khanna, GA Hecht, HL DuPont, ... Gastroenterology 154 (6), S-192, 2018 | | 2018 |
| 1657Who Seeks a Fecal Microbiota Transplant for Recurrent C. difficile Infection?: Patient Profile of the PUNCH CD Study R Orenstein, E Dubberke, C Griesbach, MK Sobcinski Open Forum Infectious Diseases 1 (Suppl 1), S443, 2014 | | 2014 |
| 1799Next Generation Fecal Transplant for Recurrent C. difficile Infection with and without Antiobiotic Pre-Treatment: Lessons Learned from the PUNCH CD Phase 2 Safety Study P Mariani, CS Price, R Orenstein, H Harris, MK Sobcinski Open Forum Infectious Diseases 1 (Suppl 1), S62, 2014 | | 2014 |
| 1950. Prevention of Recurrent Clostridium difficile at Six Months Following Treatment With Microbiota-Based Therapy RBX2660: Durability Results From a Phase 2 Open-Label Study S Mische, R Orenstein, ER Dubberke, S Khanna, G Hecht, H Dupont, ... Open Forum Infectious Diseases 5 (Suppl 1), S562, 2018 | 1 | 2018 |
| 40. Lenzilumab efficacy and safety in newly hospitalized COVID-19 subjects: results from a phase 3 randomized double-blind placebo-controlled trial Z Temesgem, C Burger, J Baker, C Polk, CR Libertin, CF Kelley, ... Open Forum Infectious Diseases 8 (Suppl 1), 29, 2021 | 1 | 2021 |
| 468RBX2660 (microbiota suspension) for Recurrent C. difficile Infection: 60-Day Interim Analysis of the PUNCH-CD Phase 2 Safety Study E Dubberke, R Orenstein, P Mariani, K Mullane, MK Sobcinski Open Forum Infectious Diseases 1 (Suppl 1), S175, 2014 | 1 | 2014 |
| 479: SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS FROM LYMPHOCYTIC CHORIOMENINGITIS VIRUS INFECTION J Chen, M Rady, B Hardaway, M Amity, J Athale, M Grill, R Orenstein, ... Critical Care Medicine 52 (1), S213, 2024 | | 2024 |
| 624–comparison of two open-label trials demonstrates similar 6-month outcomes for Rbx2660 and Rbx7455—Investigational microbiota restoration therapeutics administered by enema … K Blount, DN Gerding, S Khanna, DS Pardi, R Orenstein, ER Dubberke, ... Gastroenterology 156 (6), S-130-S-131, 2019 | 2 | 2019 |
| 699 SAFETY OUTCOMES AND CONCOMITANT MEDICATION CHANGES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE BEING TREATED WITH RBX2660 FOR RECURRENT CLOSTRIDIOIDES DIFFICILE INFECTION JR Allegretti, P Feuerstadt, WL Knapple, R Orenstein, P Pinton, ... Gastroenterology 164 (6), S-143, 2023 | | 2023 |
| A Case of Burkholderia pseudomallei Mycotic Aneurysm Linked to Exposure in the Caribbean via Whole-Genome Sequencing LJ Speiser, S Kasule, CM Hall, JW Sahl, DM Wagner, C Saling, A Kole, ... Open Forum Infectious Diseases 9 (5), ofac136, 2022 | 3 | 2022 |
| A Case of Sustained Viral Shedding of Mpox With Ocular Involvement Resulting in Vision Loss LJ Speiser, AM Wonnaparhown, J Blair, A Shah, DR Patel, ... Open Forum Infectious Diseases 11 (1), ofad632, 2024 | | 2024 |
| A framework for outpatient infusion of antispike monoclonal antibodies to high-risk patients with mild-to-moderate coronavirus disease-19: the Mayo Clinic model RR Razonable, NCE Aloia, RJ Anderson, G Anil, LL Arndt, RF Arndt, ... Mayo Clinic Proceedings 96 (5), 1250-1261, 2021 | 53 | 2021 |
| A randomized, double blind, placebo‐controlled trial of an oral synbiotic (AKSB) for prevention of travelers' diarrhea A Virk, J Mandrekar, EF Berbari, TG Boyce, PR Fischer, MJ Kasten, ... Journal of Travel Medicine 20 (2), 88-94, 2013 | 41 | 2013 |
| A targeted strategy to wipe out Clostridium difficile R Orenstein, KC Aronhalt, JE McManus, LA Fedraw Infection Control & Hospital Epidemiology 32 (11), 1137-1139, 2011 | 98 | 2011 |
| A woman with fever and rash after African safari DZ Uslan, KM Jacobson, N Kumar, EF Berbari, R Orenstein Clinical infectious diseases 43 (5), 661-662, 2006 | 10 | 2006 |
| Alterations in microbial diversity are associated with treatment success with RBX2660, a microbiota-based drug for the prevention of recurrent Clostridium difficile infection … S Khanna, GA Hecht, E Dubberke, R Orenstein, C Lee, DN Gerding Digestive Diseases 2017, 2017 | 4 | 2017 |
| An outbreak of Mycobacterium chelonae infections in association with tattoos L Drage, PK Phillips, P Ecker, R Edson, R Orenstein JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY 60 (3), AB4-AB4, 2009 | 2 | 2009 |
| An outbreak of Mycobacterium chelonae infections in tattoos LA Drage, PM Ecker, R Orenstein, PK Phillips, RS Edson Journal of the American Academy of Dermatology 62 (3), 501-506, 2010 | 118 | 2010 |
| An outbreak of neurological autoimmunity with polyradiculoneuropathy in workers exposed to aerosolised porcine neural tissue: a descriptive study DH Lachance, VA Lennon, SJ Pittock, JA Tracy, KN Krecke, KK Amrami, ... The Lancet Neurology 9 (1), 55-66, 2010 | 58 | 2010 |
| Andrew Taylor Still and the Mayo brothers: Convergence and collaboration in 21st-century osteopathic practice R Orenstein Journal of Osteopathic Medicine 105 (5), 251-254, 2005 | 5 | 2005 |
